Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

This study has been completed.
German Research Foundation
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Joerg Schirra, Ludwig-Maximilians - University of Munich Identifier:
First received: October 26, 2006
Last updated: October 2, 2011
Last verified: October 2011